These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 22197963

  • 1. Simultaneous quantification of hemagglutinin and neuraminidase of influenza virus using isotope dilution mass spectrometry.
    Williams TL, Pirkle JL, Barr JR.
    Vaccine; 2012 Mar 23; 30(14):2475-82. PubMed ID: 22197963
    [Abstract] [Full Text] [Related]

  • 2. Quantification of influenza virus hemagglutinins in complex mixtures using isotope dilution tandem mass spectrometry.
    Williams TL, Luna L, Guo Z, Cox NJ, Pirkle JL, Donis RO, Barr JR.
    Vaccine; 2008 May 12; 26(20):2510-20. PubMed ID: 18440105
    [Abstract] [Full Text] [Related]

  • 3. Simultaneous quantification of the viral antigens hemagglutinin and neuraminidase in influenza vaccines by LC-MSE.
    Creskey MC, Li C, Wang J, Girard M, Lorbetskie B, Gravel C, Farnsworth A, Li X, Smith DG, Cyr TD.
    Vaccine; 2012 Jul 06; 30(32):4762-70. PubMed ID: 22643214
    [Abstract] [Full Text] [Related]

  • 4. Quantification of immunoreactive viral influenza proteins by immunoaffinity capture and isotope-dilution liquid chromatography-tandem mass spectrometry.
    Pierce CL, Williams TL, Moura H, Pirkle JL, Cox NJ, Stevens J, Donis RO, Barr JR.
    Anal Chem; 2011 Jun 15; 83(12):4729-37. PubMed ID: 21591780
    [Abstract] [Full Text] [Related]

  • 5. Label-free mass spectrometry-based quantification of hemagglutinin and neuraminidase in influenza virus preparations and vaccines.
    Getie-Kebtie M, Sultana I, Eichelberger M, Alterman M.
    Influenza Other Respir Viruses; 2013 Jul 15; 7(4):521-30. PubMed ID: 22943763
    [Abstract] [Full Text] [Related]

  • 6. Optimization and qualification of a quantitative reversed-phase HPLC method for hemagglutinin in influenza preparations and its comparative evaluation with biochemical assays.
    Lorbetskie B, Wang J, Gravel C, Allen C, Walsh M, Rinfret A, Li X, Girard M.
    Vaccine; 2011 Apr 18; 29(18):3377-89. PubMed ID: 21397719
    [Abstract] [Full Text] [Related]

  • 7. Quantification of viral proteins of the avian H7 subtype of influenza virus: an isotope dilution mass spectrometry method applicable for producing more rapid vaccines in the case of an influenza pandemic.
    Santana WI, Williams TL, Winne EK, Pirkle JL, Barr JR.
    Anal Chem; 2014 May 06; 86(9):4088-95. PubMed ID: 24689548
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Development and fit-for-purpose verification of an LC-MS method for quantitation of hemagglutinin and neuraminidase proteins in influenza virus-like particle vaccine candidates.
    Guo J, Lu Y, Zhang Y, Mugabe S, Wei Z, Borisov OV.
    Anal Biochem; 2020 Mar 01; 592():113577. PubMed ID: 31926146
    [Abstract] [Full Text] [Related]

  • 11. Strain identification of commercial influenza vaccines by mass spectrometry.
    Creskey MC, Smith DG, Cyr TD.
    Anal Biochem; 2010 Nov 15; 406(2):193-203. PubMed ID: 20667441
    [Abstract] [Full Text] [Related]

  • 12. Haemagglutinin quantification and identification of influenza A&B strains propagated in PER.C6 cells: a novel RP-HPLC method.
    Kapteyn JC, Saidi MD, Dijkstra R, Kars C, Tjon JC, Weverling GJ, de Vocht ML, Kompier R, van Montfort BA, Guichoux JY, Goudsmit J, Lagerwerf FM.
    Vaccine; 2006 Apr 12; 24(16):3137-44. PubMed ID: 16490287
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Application of deglycosylation and electrophoresis to the quantification of influenza viral hemagglutinins facilitating the production of 2009 pandemic influenza (H1N1) vaccines at multiple manufacturing sites in China.
    Li C, Shao M, Cui X, Song Y, Li J, Yuan L, Fang H, Liang Z, Cyr TD, Li F, Li X, Wang J.
    Biologicals; 2010 Mar 12; 38(2):284-9. PubMed ID: 20074976
    [Abstract] [Full Text] [Related]

  • 16. Rapid differentiation of seasonal and pandemic H1N1 influenza through proteotyping of viral neuraminidase with mass spectrometry.
    Schwahn AB, Wong JW, Downard KM.
    Anal Chem; 2010 Jun 01; 82(11):4584-90. PubMed ID: 20443622
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. HPLC-based quantification of haemagglutinin in the production of egg- and MDCK cell-derived influenza virus seasonal and pandemic vaccines.
    Kapteyn JC, Porre AM, de Rond EJ, Hessels WB, Tijms MA, Kessen H, Slotboom AM, Oerlemans MA, Smit D, van der Linden J, Schoen P, Thus JL.
    Vaccine; 2009 Feb 25; 27(9):1468-77. PubMed ID: 19110022
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Protection abilities of influenza B virus DNA vaccines expressing hemagglutinin, neuraminidase, or both in mice.
    Fang F, Cai XQ, Chang HY, Wang HD, Yang ZD, Chen Z.
    Acta Virol; 2008 Feb 25; 52(2):107-12. PubMed ID: 18564897
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.